Supplementary Figure 1 from Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer

PDF file - 57K, Summary of tumor response and tumor genotype among patients who received treatment with panitumuab plus BSC or BSC alone in either the randomized phase 3 study or the extension and who had multigene sequencing information available. For all patients enrolled, tumor response was based on investigator assessment. BSC, best supportive care.